Elicitation of Broadly Protective Sarbecovirus Immunity by Receptor-Binding Domain Nanoparticle Vaccines

The authors showed that a clinical stage multivalent SARS-CoV-2 spike receptor-binding domain nanoparticle vaccine protected mice from SARS-CoV-2 challenge after a single immunization, indicating a potential dose-sparing strategy.